Mouse TRPV2(Transient Receptor Potential Cation Channel Subfamily V, Member 2) ELISA Kit
To Order Contact us: [email protected]
Mouse IgG ELISA (96 Determinations) |
|||
0801180 | Zeptometrix | 96T | 432 EUR |
Mouse IgM ELISA (96 Determinations) |
|||
0801181 | Zeptometrix | 96T | 432 EUR |
Digital dermatitis ELISA kit A |
|||
10-0030-1 | Medicago | 1 kit | 678 EUR |
SUDV Soluble GP (sGP) ELISA kit |
|||
0102-001 | IBT Bioservices | 1ea | 662.4 EUR |
Description:
|
|||
EBOV Soluble GP (sGP) ELISA kit |
|||
0100-001 | IBT Bioservices | 1ea | 662.4 EUR |
Description:
|
|||
Homocysteine ELISA kit, 96 tests, Quantitative |
|||
0370-HCY | Alpha Diagnostics | 1 kit | 927.6 EUR |
Vitamin B12 ELISA kit, 96 tests, Quantitative |
|||
0340-B12 | Alpha Diagnostics | 1 Kit | 927.6 EUR |
D-Dimer turbidimetric ELISA Kit, 96 tests, Quantitative |
|||
0330-DDM | Alpha Diagnostics | 1 kit | 708 EUR |
Human Procalcitonin (PCT) ELISA Kit, 96 tests, Quantitative |
|||
0380-PTC | Alpha Diagnostics | 1 kit | 927.6 EUR |
Vitamin D total (25OH) ELISA kit, 96 tests, Quantitative |
|||
0345-VID | Alpha Diagnostics | 1 kit | 708 EUR |
Human Insulin ELISA Kit, 96 tests, Quantitative, 96 tests |
|||
0030N | Alpha Diagnostics | 1 kit | 708 EUR |
Human Calcitonin ELISA Kit, ultrasensitive, 96 tests, Quantitative |
|||
0390-CTU | Alpha Diagnostics | 1 kit | 927.6 EUR |
Bovine Insulin ELISA Kit, 96 tests, Quantitative, 96 tests |
|||
0030-10-B1 | Alpha Diagnostics | 1 kit | 781.2 EUR |
Rat Insulin ELISA Kit, High Sensitivity, Quantitative, 96 tests |
|||
0030-50-1 | Alpha Diagnostics | 1 kit | 708 EUR |
Human Parathyroid Hormone (PTH) ELISA Kit, 96 tests, Quantitative |
|||
0320-PTH | Alpha Diagnostics | 1 kit | 927.6 EUR |
Vitamin B9/Folic Acid (FA) ELISA kit, 96 tests, Quantitative |
|||
0365-0B9 | Alpha Diagnostics | 1 kit | 927.6 EUR |
Human Insulin-Biotin ELISA Kit, 96 tests, Quantitative, 96 tests |
|||
0030-20-I | Alpha Diagnostics | 1 kit | 854.4 EUR |
Mouse ; Testis |
|||
02-715 | Sceti | 100ng | 481.2 EUR |
Description: The Mouse ; Testis is available in Europe and for worldwide shipping via Gentaur. |
|||
Rat Insulin ELISA Kit, High Sensitivity, Quantitative, 10x 96 tests |
|||
0030-50-10 | Alpha Diagnostics | 1 kit | 5833.2 EUR |
Mouse ; Thymocyte |
|||
02-703 | Sceti | 100ng | 481.2 EUR |
Description: The Mouse ; Thymocyte is available in Europe and for worldwide shipping via Gentaur. |
|||
Mouse anti-LTA mAb |
|||
0270-001 | IBT Bioservices | 200ug | 272.4 EUR |
Description:
|
|||
Mouse anti Human IgE |
|||
10-1025 | Fitzgerald | 1 mg | 392.4 EUR |
Description: Mouse monoclonal Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
10-1026 | Fitzgerald | 1 mg | 392.4 EUR |
Description: Mouse monoclonal Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
10-1027 | Fitzgerald | 1 mg | 392.4 EUR |
Description: Mouse monoclonal Mouse anti Human IgE antibody |
|||
Mouse anti-Hla mAb (8B7) |
|||
0210-001 | IBT Bioservices | 100ug | 540 EUR |
Description:
|
|||
Mouse anti-SEB mAb (2C1) |
|||
0220-013 | IBT Bioservices | 100ug | 394.8 EUR |
Description:
|
|||
Mouse anti-Hla mAb (6C12) |
|||
0210-005 | IBT Bioservices | 100ug | 540 EUR |
Description:
|
|||
Mouse anti-SEB mAb (3D10) |
|||
0220-009 | IBT Bioservices | 100ug | 486 EUR |
Description:
|
|||
Human Insulin & Insulin Analogs (Lispro/Humalog, Aspart, Glargine, Glulisine, Detemir) ELISA Kit, 96 tests, |
|||
0035-IA | Alpha Diagnostics | 1 kit | 927.6 EUR |
Mouse anti-SUDV GP mAb (2H5) |
|||
0202-029 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-MARV GP mAb (5C1) |
|||
0203-023 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-EBOV GP mAb (4F3) |
|||
0201-020 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-SUDV GP mAb (16F6) |
|||
0280-001 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-MARV VP40 mAb (1D1) |
|||
0203-012 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-LukS-PV mAb (1D9) |
|||
0221-001 | IBT Bioservices | 100ug | 486 EUR |
Description:
|
|||
Mouse anti-EBOV VP40 mAb (3G5) |
|||
0201-016 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-MMARV VP40 mAb (6B1) |
|||
0203-016 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-EBOV VP40 mAb (5B12) |
|||
0201-017 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-EBOV VP40 mAb (AE11) |
|||
0201-018 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Mouse anti-SUDV VP40 mAb (1G10) |
|||
0202-018 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
Pan-filovirus Mouse anti-GP mAb |
|||
0200-001 | IBT Bioservices | 100ug | 662.4 EUR |
Description:
|
|||
Mouse antibody for Epstein-Barr virus |
|||
0223 | Virostat | 100 ug | 431.93 EUR |
Description: This is Mouse monoclonal FITC conjugated antibody against Epstein-Barr virus gp 250/350 for WB, ELISA. |
|||
CA50 (Cancer antigen) ELISA test |
|||
10 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen) |
|||
Rat IgG ELISA (96 Determinations) |
|||
0801009 | Zeptometrix | 96T | 324 EUR |
Protein L Ligand Leakage ELISA |
|||
10-0027-1 | Medicago | 1 kit | 1400.4 EUR |
10X ELISA Wash Buffer (125 mL) |
|||
0801060 | Zeptometrix | 125 mL | 19 EUR |
Goat IgG ELISA (96 Determinations) |
|||
0801223 | Zeptometrix | 96T | 324 EUR |
Human IgG ELISA (96 Determinations) |
|||
0801182 | Zeptometrix | 96T | 432 EUR |
Human IgM ELISA (96 Determinations) |
|||
0801183 | Zeptometrix | 96T | 432 EUR |
Human IgA ELISA (96 Determinations) |
|||
0801197 | Zeptometrix | 96T | 432 EUR |
Horse IgG ELISA (96 Determinations) |
|||
0801221 | Zeptometrix | 96T | 324 EUR |
Bovine IgG ELISA (96 Determinations) |
|||
0801198 | Zeptometrix | 96T | 445 EUR |
Rabbit IgG ELISA (96 Determinations) |
|||
0801202 | Zeptometrix | 96T | 432 EUR |
Chicken IgY ELISA (96 Determinations) |
|||
0801010 | Zeptometrix | 96T | 324 EUR |
Protein L Ligand Leakage ELISA XL |
|||
10-0028-1 | Medicago | 1 kit | 1563.6 EUR |
Guinea Pig IgG ELISA (96 Determinations) |
|||
0801029 | Zeptometrix | 96T | 445 EUR |
HTLV p19 Antigen ELISA (96 Determinations) |
|||
0801116 | Zeptometrix | 96T | 774 EUR |
?-HCG (Human chorionic gonadotropin) ELISA test |
|||
1 | Cusabio | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of ?-HCG (Human chorionic gonadotropin) |
|||
Rabbit anti-LASV V pAb |
|||
0307-002 | IBT Bioservices | 100ug | 571.2 EUR |
Description:
|
|||
ELISA Construction System (5 X 96 Determinations) |
|||
0801188 | Zeptometrix | 5 X 96T | 345 EUR |
HIV Type 1 p24 Antigen ELISA (96 Determinations) |
|||
0801111 | Zeptometrix | 96T | 621 EUR |
HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations) |
|||
0801002 | Cusabio | 96T | 657.79 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
0801200 | Zeptometrix | 5 X 96T | 2563 EUR |
HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations) |
|||
0801008 | Zeptometrix | 5 X 96T | 2505 EUR |
Simian Immunodeficiency Virus (SIV) p27 Antigen ELISA (96 Determinations) |
|||
0801169 | Zeptometrix | 96T | 774 EUR |
NOS Inhibitor Kit |
|||
00249 | Biotium | 1SET | 381.6 EUR |
Description: Minimum order quantity: 1 unit of 1SET |
|||
Simian Immunodeficiency Virus (SIV) p27 Antigen ELISA (5 X 96 Determinations) |
|||
0801201 | Zeptometrix | 5 X 96 Determinations | 3213 EUR |
HIV-1 reverse transcriptase recombinant antigen |
|||
00198-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HIV-1 reverse transcriptase recombinant antigen. |
|||
HIV-1 reverse transcriptase recombinant antigen |
|||
00198-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HIV-1 reverse transcriptase recombinant antigen. |
|||
HIV-1Reverse transcriptase |
|||
05-001 | Sceti | 200 units | 481.2 EUR |
Description: The HIV-1Reverse transcriptase is available in Europe and for worldwide shipping via Gentaur. |
|||
HIV-1Reverse transcriptase |
|||
05-002 | Sceti | 1,000 units | 1483.2 EUR |
Description: The HIV-1Reverse transcriptase is available in Europe and for worldwide shipping via Gentaur. |
|||
Human Transferrin, CF750 conjugate |
|||
00087 | Biotium | 1mg | 186 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF543 conjugate |
|||
00082 | Biotium | 1mg | 178.8 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF568 conjugate |
|||
00083 | Biotium | 1mg | 178.8 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF594 conjugate |
|||
00084 | Biotium | 1mg | 178.8 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF680R conjugate |
|||
00086 | Biotium | 1mg | 178.8 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF488A conjugate |
|||
00081 | Biotium | 1mg | 178.8 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF640R conjugate |
|||
00085 | Biotium | 1mg | 178.8 EUR |
Description: Minimum order quantity: 1 unit of 1mg |
|||
TBARS (Thiobarbituric Acid Reactive Substances) Assay Kit (160 tests) |
|||
0801192 | Zeptometrix | 160 tests | 517 EUR |
Nitric oxide generation kit |
|||
00239 | Biotium | 1SET | 373.2 EUR |
Description: Minimum order quantity: 1 unit of 1SET |
|||
ACES™ Signal Sequence Kit |
|||
0148-2 | AthenaES | kit | 373.2 EUR |
APF Media Optimization Kit™ |
|||
0100-APF | AthenaES | kit | 146.4 EUR |
ACES™ Promoter Selection Kit |
|||
0148-1 | AthenaES | kit | 336 EUR |
BSA Calibrator [Bradford Assay Kit] |
|||
0209C | AthenaES | 0.5 ml | 123.6 EUR |
Glutathione Reductase Assay Kit (100 tests) |
|||
0805004 | Zeptometrix | 100 tests | 334.56 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Arylesterase/Paraoxonase Assay Kit (200 tests) |
|||
0801199 | Zeptometrix | 200 tests | 517 EUR |
ACES™ YebF Protein Export Kit |
|||
0148-3 | AthenaES | kit | 373.2 EUR |
Total Glutathione Peroxidase Assay Kit (100 tests) |
|||
0805002 | Zeptometrix | 100 tests | 409.44 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
000-CUS | Alpha Diagnostics | Custom | Ask for price |
Dengue NS1 antibody (Subtype 2/3) |
|||
10-1730 | Fitzgerald | 250 ug | 285.6 EUR |
Description: Mouse monoclonal Dengue NS1 antibody (Subtype 2/3) |
|||
Dengue NS1 antibody (Subtype 2/4) |
|||
10-1732 | Fitzgerald | 250 ug | 236.4 EUR |
Description: Mouse monoclonal Dengue NS1 antibody (Subtype 2/4) |
|||
HIV-1 p24 ICx/CRx (Immune Dissociation & Reactive Confirmation) Kit (100 tests) |
|||
0801096 | Zeptometrix | 100 tests | 120 EUR |
HIV Type 1 p24 Extended Range Kit (5 x 96 Determinations) |
|||
0801137 | Zeptometrix | 5 x 96T | 87 EUR |
rhIL-2 Recombinant Human Interleukin-2 (20,000 Units) |
|||
0801114 | Zeptometrix | 20,000 Units | 95 EUR |
ACE-2 Recombinant Protein |
|||
10-014 | ProSci | 0.1 mg | 714.3 EUR |
Description: Angiotensin-Converting Enzyme 2 (ACE-2) is an integral membrane protein and a zinc metalloprotease of the ACE family which includes somatic and germinal ACE. ACE-2 cleaves angiotensins I and II as a carboxypeptidase and converts angiotensin I to angiotensin 1-9, and angiotensin II to angiotensin 1-7. ACE-2 is also able to hydrolyze apelin-13 and dynorphin-13 with high efficiency. ACE-2 can be highly expressed in testis, kidney, heart, colon, small intestine and ovary at moderate levels. ACE2 is not inhibited by the classical ACE inhibitors, captopril and lisinopril and may play an important role in regulating the heart function. |
|||
LIMITED QTY-rhIL-2 Recombinant Human Interleukin-2 (100 µg) |
|||
0802001 | Zeptometrix | 100 µg | 434.4 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
2-Propyl-β-D-glucuronide, 2 mg |
|||
0904-2 | AthenaES | 2 mg | 194.4 EUR |
HSV-2 gD recombinant antigen |
|||
00182-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HSV-2 gD recombinant antigen a.a. 266-394. |
|||
HSV-2 gD recombinant antigen |
|||
00182-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HSV-2 gD recombinant antigen a.a. 266-394. |
|||
HSV-2 gD recombinant antigen |
|||
00183-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HSV-2 gD recombinant antigen a.a. 525-578. |
|||
HSV-2 gD recombinant antigen |
|||
00183-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HSV-2 gD recombinant antigen a.a. 525-578. |
|||
HIV-2 gp32 recombinant antigen |
|||
00173-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HIV-2 gp32 recombinant antigen. . |
|||
HIV-2 gp32 recombinant antigen |
|||
00173-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HIV-2 gp32 recombinant antigen. . |
|||
2, 3-Diaminonaphthalene |
|||
00301 | Biotium | 100MG | 121.2 EUR |
Description: Minimum order quantity: 1 unit of 100MG |
|||
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
|||
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
|||
HIV -2 env gp36 recombinant antigen |
|||
00179-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
|||
HIV -2 env gp36 recombinant antigen |
|||
00179-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
|||
HCV core 2-119aa recombinant antigen |
|||
00150-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
|||
HCV core 2-119aa recombinant antigen |
|||
00150-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
|||
HIV 1, 2 envelope recombinant antigen |
|||
00175-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. |
|||
HIV 1, 2 envelope recombinant antigen |
|||
00175-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. |
|||
DAA (1, 2-diaminoanthraquinone) |
|||
00300 | Biotium | 10MG | 186 EUR |
Description: Minimum order quantity: 1 unit of 10MG |
|||
rHu IL 2 , 3MIU |
|||
04-RHIL2-02F01 | Gentaur Genprice | 1 vial | 298.8 EUR |
Description: Recombinant human interleukin-2 is a sterile protein product for injection. rHuIL-2 is produced by recombinant DNA technology using Yeast. It is a highly purified protein containing 133 amino acids, with cysteine mutated to alanine at 125 amino acid position, and has a molecular weight of approximately 15.4kD, non-glycosylated. |
|||
alpha 2 Antiplasmin antibody |
|||
10-1502 | Fitzgerald | 500 ug | 444 EUR |
Description: Mouse monoclonal alpha 2 Antiplasmin antibody |
|||
alpha 2 Antiplasmin antibody |
|||
10-1503 | Fitzgerald | 500 ug | 444 EUR |
Description: Mouse monoclonal alpha 2 Antiplasmin antibody |
|||
beta 2 Microglobulin antibody |
|||
10-1560 | Fitzgerald | 1 mg | 470.4 EUR |
Description: Mouse monoclonal beta 2 Microglobulin antibody |
|||
beta 2 Microglobulin antibody |
|||
10-1561 | Fitzgerald | 1 mg | 470.4 EUR |
Description: Mouse monoclonal beta 2 Microglobulin antibody |
|||
Dengue Type 2 antibody |
|||
10-1706 | Fitzgerald | 500 ug | 678 EUR |
Description: Mouse monoclonal Dengue Type 2 antibody |
|||
SARS-CoV-2 (COVID-19) RBD Recombinant Protein |
|||
10-078 | ProSci | 0.1 mg | 619.8 EUR |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). The CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. Although both SARS-CoV and SARS-CoV-2 bind the ACE2 receptor, the RBDs only share ~73% amino acid identity, and the SARS-CoV-2 RBD binds with a higher affinity compared to SARS-CoV 3, 6. The RBD is dynamic and undergoes hinge-like conformational changes, referred to as the “down” or “up” conformations, which hide or expose the receptor-binding motifs, respectively 7. Following receptor binding, S1 destabilizes, and TMPRSS2 cleaves S2, which undergoes a pre- to post-fusion conformation transition, allowing for membrane fusion 8, 9. _x000D__x000D__x000D_Polyclonal RBD-specific antibodies can block ACE2 binding 10, 11, and anti-RBD neutralizing antibodies are present in the sera of convalescent COVID19 patients 12, identifying the RBD as an attractive candidate for vaccines and therapeutics. In addition, the RBD is poorly conserved, making it a promising antigen for diagnostic tests 13 14. Serologic tests for the RBD are highly sensitive and specific for detecting SARS-CoV-2 antibodies in COVID19 patients 13 15. Furthermore, the levels of anti-RBD antibodies correlated with SARS-CoV-2 neutralizing antibodies, suggesting the RBD could be used to predict an individual's risk of disease 13._x000D_ |
|||
SARS-CoV-2 (COVID-19) NTD Recombinant Protein |
|||
10-079 | ProSci | 0.1 mg | 821.4 EUR |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). In both SARS-CoV and SARS-CoV-2, the CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells3-5. The NTD of SARS-CoV-2 does not bind to ACE26, and the function of NTD in SARS-CoV-2 infection is not well understood. In other CoVs, the NTD may promote attachment by binding to sugar moieties7 and might play a role in the conformational change of S2 required for membrane fusion8. While most neutralizing antibodies target the RBD domain and block receptor binding, potent neutralizing antibodies targeting NTD were isolated from convalescent COVID19 patients9, identifying the NTD as an attractive candidate for vaccines and therapeutics. In addition, the NTD is a promising antigen for diagnostic tests, as there is only 53.5% homology between the NTD of SARS-CoV-2 and SARS-CoV10. |
|||
SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein |
|||
10-002 | ProSci | 0.1 mg | 714.3 EUR |
Description: LOCUS: QHD43422 121aa linear VRL 18-MAR-2020 |
|||
SARS-CoV-2 (COVID-19) ORF3a Recombinant Protein |
|||
10-005 | ProSci | 0.1 mg | 714.3 EUR |
Description: LOCUS: QHD43417 275aa linear VRL 18-MAR-2020 |
|||
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein |
|||
10-112 | ProSci | 0.1 mg | 726.9 EUR |
Description: SARS-CoV-2 (COVID-19) Envelope Recombinant Protein |
|||
HIV 2 gp36 envelope antigen |
|||
00180-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. |
|||
HIV 2 gp36 envelope antigen |
|||
00180-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. |
|||
anti-HIV-2 gp36 IgG1 |
|||
0114-A-01mg | Virogen | 0,1 mg | 321 EUR |
Description: anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
anti-HIV-2 gp36 IgG1 |
|||
0114-A-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
Trichosanthes japonica agglutinin 2 (TJA) |
|||
05-0033-100 | Medicago | 100 mg | 2701.2 EUR |
Trichosanthes japonica agglutinin 2 (TJA) |
|||
05-0033-2 | Medicago | 2 mg | 366 EUR |
Trichosanthes japonica agglutinin 2 (TJA) |
|||
05-0033-25 | Medicago | 25 mg | 932.4 EUR |
SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein |
|||
10-113 | ProSci | 0.1 mg | 726.9 EUR |
Description: SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein |
|||
Natural Human Interleukin-2 (IL-2) / (TCGF) (50 mL, 25,000 BRMP Units) |
|||
0801017 | Zeptometrix | 50 mL, 25,000 BRMP Units | 321 EUR |
NATtrol SARS-CoV-2 (recombinant) Stock (1 x 1.0mL) |
|||
0831042 | Zeptometrix | - | 693 EUR |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-107 | ProSci | 0.1 mg | 651.3 EUR |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
|||
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-109 | ProSci | 0.1 mg | 651.3 EUR |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
|||
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-111 | ProSci | 0.1 mg | 651.3 EUR |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
|||
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-118 | ProSci | 0.1 mg | 651.3 EUR |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
|||
10-100 | ProSci | 0.1 mg | 651.3 EUR |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
|||
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
|||
10-117 | ProSci | 0.1 mg | 752.1 EUR |
Description: SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
|||
SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein |
|||
10-008 | ProSci | 0.1 mg | 714.3 EUR |
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus. |
|||
SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein |
|||
10-015 | ProSci | 0.1 mg | 714.3 EUR |
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus. |
|||
SARS-CoV-2 (COVID-19) Nucleocapsid (N) Recombinant Protein |
|||
10-080 | ProSci | 0.1 mg | 619.8 EUR |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). In both SARS-CoV and SARS-CoV-2, the CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. The NTD of SARS-CoV-2 does not bind to ACE2 6, and the function of NTD in SARS-CoV-2 infection is not well understood. In other CoVs, the NTD may promote attachment by binding to sugar moieties 7 and might play a role in the conformational change of S2 required for membrane fusion 8. While most neutralizing antibodies target the RBD domain and block receptor binding, potent neutralizing antibodies targeting NTD were isolated from convalescent COVID19 patients 9, identifying the NTD as an attractive candidate for vaccines and therapeutics. In addition, the NTD is a promising antigen for diagnostic tests, as there is only 53.5% homology between the NTD of SARS-CoV-2 and SARS-CoV 10. |
|||
rHu IL 2 , 3MIU , Lot 200908F02 |
|||
04-RHIL2-08F02 | Gentaur Genprice | 1 vial | 298.8 EUR |
Description: Recombinant human interleukin-2 is a sterile protein product for injection. rHuIL-2 is produced by recombinant DNA technology using Yeast. It is a highly purified protein containing 133 amino acids, with cysteine mutated to alanine at 125 amino acid position, and has a molecular weight of approximately 15.4kD, non-glycosylated. |
|||
Ethyl-β-D-glucuronide, 2 mg |
|||
0901-2 | AthenaES | 2 mg | 194.4 EUR |
Ethyl sulfate, sodium salt, 2 mg |
|||
0902-2 | AthenaES | 2 mg | 82.8 EUR |
Propyl-β-D-glucuronide, 2 mg |
|||
0903-2 | AthenaES | 2 mg | 194.4 EUR |
SARS-CoV-2 (COVID-19) Spike S2 ECD Recombinant Protein |
|||
10-115 | ProSci | 0.1 mg | 651.3 EUR |
Description: SARS-CoV-2 (COVID-19) Spike S2 ECD Recombinant Protein |
|||
SARS-CoV-2 (COVID-19) Trimeric Spike (S) Recombinant Protein |
|||
10-075 | ProSci | 0.1 mg | 991.5 EUR |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). The CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. Although both SARS-CoV and SARS-CoV-2 bind the ACE2 receptor, the RBDs only share ~73% amino acid identity, and the SARS-CoV-2 RBD binds with a higher affinity compared to SARS-CoV 3, 6. The RBD is dynamic and undergoes hinge-like conformational changes, referred to as the “down” or “up” conformations, which hide or expose the receptor-binding motifs, respectively 7. Following receptor binding, S1 destabilizes, and TMPRSS2 cleaves S2, which undergoes a pre- to post-fusion conformation transition, allowing for membrane fusion 8, 9. The S protein has been the main focus of therapeutic and vaccine design as it is highly immunogenic. Both neutralizing antibodies 10,11 and memory T cells 12,13 targeting the S protein are present in the sera of convalescent COVID-19 patients. |
|||
NATtrol SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x 1.0mL) |
|||
0831043 | Zeptometrix | - | 693 EUR |
Ethyl-β-D-glucuronide-d5, 2 mg |
|||
0901D-2 | AthenaES | 2 mg | 463.2 EUR |
Ethyl sulfate-d5, sodium salt, 2 mg |
|||
0902D-2 | AthenaES | 2 mg | 110.4 EUR |
2-Propyl-β-D-glucuronide, 10 mg |
|||
0904-10 | AthenaES | 10 mg | 664.8 EUR |
Ethyl-β-D-glucuronide-13C6, 2 mg |
|||
0905-2 | AthenaES | 2 mg | 439.2 EUR |
SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD) Recombinant Protein |
|||
10-108 | ProSci | 0.1 mg | 1186.8 EUR |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
|||
SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD) Recombinant Protein |
|||
10-121 | ProSci | 0.1 mg | 1186.8 EUR |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |